Trial intelligence / Profile preview

Non-Nicotine Agents for Smoking Cessation

NCT00108537Phase 3Completed

Sponsor
United States Department of Veterans Affairs
Start
Oct 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by United States Department of Veterans Affairs. Started Oct 2003; status: completed.

02

Drugs

bupropion
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00108537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00108537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call